Neptune Technologies & Bioresources Misses on the Top and Bottom Lines
Neptune Technologies & Bioresources (NAS: NEPT) reported earnings on May 29. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Feb. 29 (Q4), Neptune Technologies & Bioresources missed estimates on revenues and missed expectations on earnings per share.
Compared to the prior-year quarter, revenue grew significantly and GAAP earnings per share expanded.
Margins grew across the board.
Neptune Technologies & Bioresources logged revenue of $5.4 million. The two analysts polled by S&P Capital IQ anticipated sales of $5.8 million on the same basis. GAAP reported sales were 29% higher than the prior-year quarter's $4.2 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at -$0.01. The two earnings estimates compiled by S&P Capital IQ predicted $0.00 per share. GAAP EPS were $0.01 for Q4 against -$0.05 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 53.8%, 6,760 basis points better than the prior-year quarter. Operating margin was -16.4%, 2,660 basis points better than the prior-year quarter. Net margin was 9.2%, 5,860 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $5.3 million. On the bottom line, the average EPS estimate is -$0.01.
Next year's average estimate for revenue is $27.0 million. The average EPS estimate is $0.03.
The stock has a one-star rating (out of five) at Motley Fool CAPS, with 23 members out of 162 rating the stock outperform, and 139 members rating it underperform. Among 87 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), three give Neptune Technologies & Bioresources a green thumbs-up, and 84 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Neptune Technologies & Bioresources is outperform, with an average price target of $9.09.
Over the decades, small-cap stocks like Neptune Technologies & Bioresources have produced market-beating returns, provided they're value-priced and have solid businesses. Read about a pair of companies with a lock on their markets in "Too Small to Fail: 2 Small Caps the Government Won't Let Go Broke." Click here for instant access to this free report.
- Add Neptune Technologies & Bioresources to My Watchlist.
At the time this article was published Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.